Northland Capital Markets Upgrades Protagonist Therapeutics (PTGX) to Outperform
Go back to Northland Capital Markets Upgrades Protagonist Therapeutics (PTGX) to Outperform| (NASDAQ: PTGX) | Delayed: 148.29 -1.71 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.00 | 52 Week High | $24.52 | |||
| Open | $151.88 | 52 Week Low | $10.02 | |||
| Day High | $151.88 | P/E | N/A | |||
| Day Low | $147.37 | EPS | $0.00 | |||
| Volume | 306,546 | |||||
